首页> 美国卫生研究院文献>Neuropsychiatric Disease and Treatment >Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates
【2h】

Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates

机译:牛脑苷和木质素注射液可改善APPswe / PS1dE9小鼠的认知障碍这些小鼠被用作抗阿兹海默症的多靶点候选药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCattle encephalon glycoside and ignotin injection (CEGI), a multitargeted neurotrophic drug, has been widely used in the treatment of central and peripheral nerve injuries, such as stroke, hypoxic ischemic encephalopathy, and diabetic neuropathy in the People’s Republic of China. However, data regarding the effect of CEGI on Alzheimer’s disease (AD) remain scarce. The present study aimed to investigate the effect of CEGI on learning and memory in an APPswe/PS1dE9 double-transgenic mouse model, a suitable animal model of AD, and elucidate its possible mechanisms.
机译:背景牛脑苷和木质素注射液(CEGI)是一种多靶点神经营养药物,在中华人民共和国中已广泛用于治疗中枢和周围神经损伤,例如中风,缺氧缺血性脑病和糖尿病性神经病。但是,关于CEGI对阿尔茨海默氏病(AD)影响的数据仍然很少。本研究旨在调查CEGI对APPswe / PS1dE9双转基因小鼠模型(一种适合AD的动物模型)的学习和记忆的影响,并阐明其可能的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号